Concepedia
Statistics
Publications
52
Citations
4.9K
H-Index
28
Active since
1988
Affiliations
Roche (United States)(Current)
Humboldt-Universität zu Berlin
Heidelberg University
Charité - Universitätsmedizin Berlin
Goethe University Frankfurt
P. Scigalla is an author at Roche (United States) specializing in medicine, erythropoiesis-stimulating therapy, and pharmacology.
Publications per year
1988–2019
Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer
Sandrine Faivre, Catherine Delbaldo, Karina Vera et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text
Pharmacy, Oncology, Pharmacology +17
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease
Walter Fiedler, Hubert Serve, Hartmut Döhner et al. · Blood · 2005 · 492 citations
Medicine, Oncology, Pharmacology +13
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Wanja M. Bernhardt, Michael S. Wiesener, P. Scigalla et al. · Journal of the American Society of Nephrology · 2010 · 342 citations · Full text
Medicine, Nephrology, Pharmacology +13
An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.
A O’Farrell, James M. Foran, Walter Fiedler et al. · PubMed · 2003 · 311 citations
Medicine, Pharmacokinetics, Pharmacology +17
The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth-Weight Infants
Rolf F. Maier, Michael Obladen, P. Scigalla et al. · New England Journal of Medicine · 1994 · 272 citations · Full text
Medicine, Hematology, Pediatrics +17
1–5 of 52